These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10702928)

  • 1. Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.
    De Rienzo F; Fanelli F; Menziani MC; De Benedetti PG
    J Comput Aided Mol Des; 2000 Jan; 14(1):93-116. PubMed ID: 10702928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ.
    Lozano JJ; López-de-Briñas E; Centeno NB; Guigó R; Sanz F
    J Comput Aided Mol Des; 1997 Jul; 11(4):395-408. PubMed ID: 9334905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 substrate specificities, substrate structural templates and enzyme active site geometries.
    Lewis DF; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Drug Metabol Drug Interact; 1999; 15(1):1-49. PubMed ID: 10707112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
    Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
    Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
    Emoto C; Iwasaki K
    Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochromes P450 and metabolism of xenobiotics.
    Anzenbacher P; Anzenbacherová E
    Cell Mol Life Sci; 2001 May; 58(5-6):737-47. PubMed ID: 11437235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytochrome P450s: selectivity and measurement in vivo.
    Smith DA; Abel SM; Hyland R; Jones BC
    Xenobiotica; 1998 Dec; 28(12):1095-128. PubMed ID: 9890156
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism.
    Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1997 Apr; 27(4):319-39. PubMed ID: 9149373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
    Islam SA; Wolf CR; Lennard MS; Sternberg MJ
    Carcinogenesis; 1991 Dec; 12(12):2211-9. PubMed ID: 1747920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamily.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Drug Metab; 2006 Aug; 7(6):589-98. PubMed ID: 16918314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional effects of cytochrome
    Bart AG; Scott EE
    J Biol Chem; 2017 Dec; 292(51):20818-20833. PubMed ID: 29079577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of tauromustine in liver and lung microsomes from various species.
    Tuvesson H; Gunnarsson PO; Seidegård J
    Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building.
    Koymans LM; Vermeulen NP; Baarslag A; Donné-Op den Kelder GM
    J Comput Aided Mol Des; 1993 Jun; 7(3):281-9. PubMed ID: 8377025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6.
    Kirton SB; Kemp CA; Tomkinson NP; St-Gallay S; Sutcliffe MJ
    Proteins; 2002 Nov; 49(2):216-31. PubMed ID: 12211002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.